Literature DB >> 10909034

Cystic hygroma of the head and neck--a long-term follow-up of 44 cases.

B Charabi1, P Bretlau, M Bille, M Holmelund.   

Abstract

Cystic hygroma of the neck is a relatively rare congenital malformation usually diagnosed during the first years of infancy. Complete surgical extirpation may be impossible without sacrificing important neurovascular structures. This paper reports the long-term outcome of surgical treatment during a 35-year period. A follow-up examination of 44 patients (24 males and 20 females) treated in our departments during the last 35 years was performed. Median age at first operation was 1.5 years (0-28 years) The observation period ranged between 1 and 36 years, median 16.2 years. Indications for operation were space occupying lesion, haemorrhage, dysphagia, difficulties in pronunciation or breathing and infection or nerve lesions. Fifty percent of the patients revealed residual or recurrent hygroma at the time of follow-up. Forty-four percent suffered from impaired speech, food intake, breathing or swallowing. Thirty-six percent were cosmetically bothered, and only 11% reported reduced quality of life. A significant correlation was noted between the extension of the lesion and (i) the number of operations performed and (ii) the rate of recurrent or residual hygroma. The rate of residual or recurrent hygroma was statistically higher for the suprahyoid lesions compared with the infrahyoid lesions. The localization and extent of the lesion is related to the surgical outcome. Surgical intervention should be centralized and should be considered carefully. Neurovascular structures should not be damaged in an attempt to effect complete removal. The above-mentioned results lead to a search for a new therapeutic modality, and the authors have recently taken up the Japanese way of treating hygromas by intralesional injection of OK-432. The first two patients treated by this technique had total regression of the lesion, and the method seems to be promising as an alternative to surgery.

Entities:  

Mesh:

Year:  2000        PMID: 10909034     DOI: 10.1080/000164800454530

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  8 in total

1.  Site-specific induction of lymphatic malformations in a rat model for image-guided therapy.

Authors:  Robert F Short; William E Shiels; Thomas J Sferra; Kathleen K Nicol; Minka Schofield; Gregory J Wiet
Journal:  Pediatr Radiol       Date:  2007-03-31

2.  The Lymphatic Malformation Function (LMF) Instrument.

Authors:  Erin M Kirkham; Todd C Edwards; Edward M Weaver; Karthik Balakrishnan; Jonathan A Perkins
Journal:  Otolaryngol Head Neck Surg       Date:  2015-07-20       Impact factor: 3.497

3.  A frog in the throat? An expansile mass presenting in the neck with dysphonia.

Authors:  Miran Pankhania; Owen Judd; Peter J Conboy
Journal:  BMJ Case Rep       Date:  2011-05-16

4.  Non surgical management of cystic lymphangioma.

Authors:  J D Rawat; Shandip Kumar Sinha; Ravi P Kanojia; Asish Wakhlu; S N Kureel; R K Tandon
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2006-10

5.  Spontaneously Resolved Macrocystic Lymphatic Malformations: Predictive Variables and Outcomes.

Authors:  Michael J Phang; Douglas J Courtemanche; Marija Bucevska; Claudia Malic; Jugpal S Arneja
Journal:  Plast Surg (Oakv)       Date:  2017-03-13       Impact factor: 0.947

6.  Lymphangioma: Is intralesional bleomycin sclerotherapy effective?

Authors:  Z Rozman; R R Thambidorai; A M Zaleha; Z Zakaria; M A Zulfiqar
Journal:  Biomed Imaging Interv J       Date:  2011-07-01

7.  Neck masses in paediatric population: An experience with children attended the Central Teaching Hospital of Pediatrics in Baghdad 2008-2009.

Authors:  Ali F Al-Mayoof
Journal:  Afr J Paediatr Surg       Date:  2015 Apr-Jun

8.  Results of Injection Sclerotherapy with Bleomycin in Pediatric Lymphatic Malformations.

Authors:  Vipan Kumar; Subhasis Roy Choudhury; Partap Singh Yadav; Vikram Khanna; Amit Gupta; Rajiv Chadha; Rama Anand
Journal:  J Indian Assoc Pediatr Surg       Date:  2021-07-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.